Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
95.57B | 88.42B | 102.30B | 101.20B | 86.67B | Gross Profit |
21.92B | 20.87B | 22.69B | 21.89B | 20.14B | EBIT |
6.24B | 5.21B | 5.62B | 4.91B | 4.15B | EBITDA |
6.24B | 8.75B | 7.60B | 12.02B | 9.93B | Net Income Common Stockholders |
4.59B | 3.21B | 2.44B | 5.56B | 3.25B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
3.63B | 7.37B | 8.88B | 10.01B | 10.34B | Total Assets |
79.75B | 82.09B | 89.61B | 92.73B | 123.42B | Total Debt |
24.57B | 25.99B | 30.48B | 27.96B | 40.45B | Net Debt |
20.93B | 18.63B | 21.60B | 17.95B | 30.10B | Total Liabilities |
81.13B | 84.40B | 92.64B | 94.31B | 115.39B | Stockholders Equity |
-1.48B | -2.40B | -3.12B | -1.69B | 2.95B |
Cash Flow | Free Cash Flow | |||
1.87B | 5.92B | 562.00M | 7.51B | 9.32B | Operating Cash Flow |
4.52B | 8.68B | 3.56B | 10.31B | 11.41B | Investing Cash Flow |
-2.21B | -2.78B | -3.02B | 1.31B | -460.00M | Financing Cash Flow |
-5.82B | -7.09B | -1.63B | -16.61B | -5.95B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
69 Neutral | $15.71B | 14.08 | 114.33% | 2.71% | 5.46% | 23.49% | |
69 Neutral | $17.70B | 14.40 | 32.21% | ― | 124.51% | 87.78% | |
68 Neutral | $14.13B | 12.21 | -109.27% | 4.25% | 24.17% | ― | |
68 Neutral | $10.62B | 7.29 | 13.99% | ― | 38.59% | ― | |
63 Neutral | $49.99B | 11.23 | -179.12% | 2.48% | 7.84% | 42.63% | |
61 Neutral | $21.31B | 8.12 | 84.33% | 5.00% | 1.03% | -18.56% | |
57 Neutral | $18.52B | 9.81 | -13.96% | 2.71% | 5.07% | -23.65% |